Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Veneorology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.
Hangzhou Normal University, Hangzhou, China.
Exp Dermatol. 2023 Jun;32(6):766-776. doi: 10.1111/exd.14762. Epub 2023 Feb 20.
Serine protease inhibitor B7 (SERPINB7) mutations have been reported to cause Nagashima-type palmoplantar keratosis (NPPK), but their biological effects are largely unknown. We conducted whole-exome sequencing and identified a c.796C>T (p.Arg266Ter) mutation in SERPINB7 in a Chinese pedigree, which presented as an autosomal recessive inheritance pattern. We assessed the function of SERPINB7 in homozygous and heterozygous mutation carriers, and the results suggested that the single c.796C>T mutation may alter the subcellular localization of SERPINB7. One of the homozygous mutation patients (II-3) was treated with ixekizumab and showed moderate improvement in keratinization. In addition, we analysed the spatiotemporal expression of serpinb1l1 and serpinb1l3, the zebrafish homologue of human SERPINB7, which is expressed in larvae and adults. In larvae, both serpinb1l1 and serpinb1l3 were expressed in the digestive tract. Then, we performed RT-PCR on adult fins based on similarity to the site of NPPK expression in humans and found that the genes were expressed in five fins (pectoral, pelvic, dorsal, anal and caudal) of the zebrafish distal extremity. Taken together, our results demonstrated that the single c.796C>T (p.Arg266Ter) mutation may alter the location of SERPINB7-encoded protein in the skin, while zebrafish SERPINB7 homologue was expressed in adult fins. These findings will enable us to construct knock-out models to explore the pathogenesis of palmoplantar keratosis.
丝氨酸蛋白酶抑制剂 B7 (SERPINB7) 突变已被报道可导致 Nagashima 型掌跖角化病 (NPPK),但其生物学效应在很大程度上尚不清楚。我们进行了全外显子组测序,在一个中国家系中发现了 SERPINB7 的 c.796C>T (p.Arg266Ter) 突变,呈常染色体隐性遗传模式。我们评估了 SERPINB7 在纯合和杂合突变携带者中的功能,结果表明单个 c.796C>T 突变可能改变 SERPINB7 的亚细胞定位。一位纯合突变患者 (II-3) 接受了 ixekizumab 治疗,角化改善程度为中度。此外,我们分析了丝氨酸蛋白酶抑制剂 B1L1 和丝氨酸蛋白酶抑制剂 B1L3 的时空表达,丝氨酸蛋白酶抑制剂 B1L3 是人类 SERPINB7 的斑马鱼同源物,在幼虫和成年期表达。在幼虫中,serpinb1l1 和 serpinb1l3 在消化道中均有表达。然后,我们根据与人类 NPPK 表达部位的相似性,在成年鱼鳍上进行 RT-PCR,发现该基因在鱼鳍的五个部位(胸鳍、腹鳍、背鳍、臀鳍和尾鳍)表达。总之,我们的研究结果表明,单个 c.796C>T (p.Arg266Ter) 突变可能改变 SERPINB7 编码蛋白在皮肤中的位置,而斑马鱼 SERPINB7 同源物在成年鱼鳍中表达。这些发现将使我们能够构建敲除模型,以探索掌跖角化病的发病机制。